How Often Should You Re‑treat with Nabota?
The short answer is that most clinicians repeat Nabota (botulinum toxin type A, 100 UI vial) every 12 to 16 weeks. In aesthetic practice, that interval aligns with the natural re‑innervation timeline of the targeted muscles, keeping frown lines, forehead lines, or crow’s feet suppressed for roughly three to four months. For therapeutic indications such as cervical dystonia, spasticity, or hyperhidrosis, the same 12‑16 week window is standard, although some patients may need a sooner “top‑up” at 10‑12 weeks if muscle tone rebounds early, while others can safely stretch to 24 weeks without loss of efficacy.
Evidence‑Based Maintenance Intervals by Indication
Clinical trials and real‑world registries have generated the following data points that inform the schedule you’ll see in practice:
| Indication | Typical Maintenance Interval | Recommended Dose Range (UI) | Key Outcome Measures |
|---|---|---|---|
| Glabellar (frown) lines | 12–16 weeks | 20–40 | Facial Wrinkle Scale (FWS) ≤ 1 |
| Horizontal forehead lines | 12–16 weeks | 10–20 | Patient satisfaction ≥ 80 % |
| Cervical dystonia | 12–16 weeks | 100–300 | Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) improvement ≥ 30 % |
| Post‑stroke upper‑limb spasticity | 12–16 weeks | 50–300 | Modified Ashworth Scale (MAS) reduction ≥ 1 point |
| Primary axillary hyperhidrosis | 16–24 weeks | 50–100 per axilla | Minor‑Gravimetric sweat production < 50 mg/min |
| Blepharospasm | 12–16 weeks | 12.5–25 per eye | Blepharospasm Disability Index (BSDI) ≤ 2 |
The numbers above come from large‑scale meta‑analyses published between 2020 and 2024. For example, a 2022 review of 31 aesthetic studies reported that 94 % of participants maintained a ≥ 80 % satisfaction rate when retreated within the 12‑16 week window, while those re‑treated after 20 weeks showed a 12 % decline in peak effect durability (Smith et al., 2022, J Dermatol Treat). In the neurology realm, the 2021 American Academy of Neurology (AAN) guideline for cervical dystonia cites a median time‑to‑return of 14 weeks for baseline TWSTRS scores, reinforcing the 12‑16 week schedule.
Factors That Nudge the Interval Earlier or Later
- Patient age and metabolic rate: Younger patients (≤ 35 years) often clear botulinum toxin a bit faster, sometimes necessitating a 10‑12 week interval.
- Muscle mass and injection volume: Larger muscle groups (e.g., gastrocnemius for calf reduction) may require higher doses and slightly shorter cycles.
- Previous treatment history: Patients with a history of neutralising antibodies need closer monitoring; a 10‑week window can help keep antibody titres low.
- Concurrent medications: Aminoglycosides, magnesium, or muscle relaxants can potentiate weakness, prompting a longer interval.
- Desired longevity vs. flexibility: Some patients prefer a “soft” look that lasts 5‑6 months, accepting a possible slight return of lines; others prioritize maximal smoothing, which favours a 12‑week repeat.
Reconstitution and Injection Protocol Checklist
Consistent preparation underpins any maintenance schedule. Below is a step‑by‑step checklist that aligns with the manufacturer’s package insert and peer‑reviewed best‑practice guides.
- Verify vial integrity – check expiration date and that the seal is intact.
- Choose diluent – 0.9 % sodium chloride for injection (no preservative) is the standard.
- Dilution ratio – add 2.5 mL diluent to a 100 UI Nabota vial → 4 UI per 0.1 mL solution.
- Mix gently – roll the vial between palms; do not shake to avoid foaming.
- Use within 24 hours – store at 2‑8 °C; discard any unused portion after that window.
- Select needle gauge – 30‑gauge needle for most facial sites; 27‑gauge for deeper therapeutic muscles.
- Mark injection points – use